Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period

Modern Pathology

Volumn 18, Issue 10, 2005, Pages 1357-1364

  Bhoopat, Lertlakana ^a   Khunamornpong, Surapan ^a   Sirivatanapa, Pannee ^a   Rithaporn, Tat ^a   Lerdsrimongkol, Piyaporn ^a   Thorner, Paul S ^b,c   Bhoopat, Tanin ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chorioamnionitis; Fetal transmission; HIV 1 subtype E; Placenta

Indexed keywords

ANTIVIRUS AGENT; CAPSID PROTEIN; GAG PROTEIN;

ARTICLE; CELL DEATH; CELL TYPE; CELLULAR DISTRIBUTION; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; FETUS; FIBROSIS; GESTATION PERIOD; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE 3; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFARCTION; INTERMETHOD COMPARISON; MICROSCOPY; NONHUMAN; PLACENTA; PLACENTA VILLUS; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THERAPEUTIC ABORTION; TISSUE NECROSIS; TROPHOBLAST; VIRUS CAPSID; VIRUS DETECTION; VIRUS STRAIN; VIRUS TRANSMISSION;

CHORIOAMNIONITIS; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; GESTATIONAL AGE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROVIRUSES;

EID: 25144506742     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800418     Document Type: Article

References (47)

1. Oxtoby M. Perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J 1990;9:609-619.
2. Scott G, Fischl M, Klimas N, et al. Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA 1985;253:363-366.
3. Minkoff H, Burns D, Landesman S, et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995;173:858-859.
4. Bryson Y. Perinatal HIV-1 transmission: recent advances and therapeutic interventions. AIDS 1996;10(Suppl 3):S33-S42.
5. Kuhn L, Abrams E, Matheson P, et al. Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS 1997;11:429-435.
6. Mock P, Shaffer N, Bhadrakom C, et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. AIDS 1999;13:407-414.
7. Douglas G, King B. Maternal-fetal transmission of human immunodeficiency virus: a review of possible routes and cellular mechanisms of infection. Clin Infect Dis 1992;15:678-691.
8. Hoff R, Berardi V, Weiblen B, et al. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med 1988;318:525-530.
9. Anderson V. The placental barrier to maternal HIV infection. Obstet Gynecol Clin North Am 1997;24:797-820.
10. Halsey N, Boulos R, Holt E, et al. Transmission of HIV-1 infections from mothers to infants in Haiti. Impact on childhood mortality and malnutrition. The CDS/JHU AIDS Project Team. JAMA 1990;264:2088-2092.
11. Braddick M, Kreiss J, Embree J, et al. Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS 1990;4:1001-1105.
12. Adjorlolo-Johnson G, De Cock K, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994;272:462-466.
13. Lepage P, Van de Perre P, Msellati P, et al. Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. Am J Epidemiol 1993;137:589-599.
14. Bobat R, Coovadia H, Coutsoudis A, et al. Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa. Pediatr Infect Dis J 1996;15:604-610.
15. Newell M, Dunn D, Peckham C, et al. Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. AIDS 1996;10:1675-1681.
16. Andiman W. Transmission of HIV-1 from mother to infant. Curr Opin Pediatr 2002;14:78-85.
17. Ryder R, Nsa W, Hassig S, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989;320:1637-1642.
18. St Louis M, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269:2853-2859.
19. Temmerman M, Nyong'o A, Bwayo J, et al. Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection. Am J Obstet Gynecol 1995;172(2, Part 1):700-705.
20. Wabwire-Mangen F, Gray R, Mmiro F, et al. Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda. J Acquir Immune Defic Syndr 1999;22:379-385.
21. Ladner J, Leroy V, Hoffman P, et al. Chorioamnionitis and pregnancy outcome in HIV-infected African women. Pregnancy and HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:293-298.
22. Lapointe N, Michaud J, Pekovic D, et al. Transplacental transmission of HTLV-III virus. N Engl J Med 1985;312:1325-1326.
23. Jovaisas E, Koch M, Schafer A, et al. LAV/HTLV-III in 20-week fetus. Lancet 1985;2:1129.
24. Sprecher S, Soumenkoff G, Puissant F, et al. Vertical transmission of HIV in 15-week fetus. Lancet 1986;2:288-289.
25. Soeiro R, Rubinstein A, Rashbaum W, et al. Maternofetal transmission of AIDS: frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA. J Infect Dis 1992;166:699-703.
26. Lewis S, Reynolds-Kohler C, Fox H, et al. HFV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 1990;335:565-568.
27. Artenstein A, Coppola J, Brown A, et al. Multiple introductions of HIV-1 subtype E into the western hemisphere. Lancet 1995;346:1197-1198.
28. Schwartz D, Sungkarat S, Shaffer N, et al. Placental abnormalities associated with human immunodeficiency virus type 1 infection and perinatal transmission in Bangkok, Thailand. J Infect Dis 2000;182:1652-1657.
29. Quiros E, Garcia F, Gonzalez I, et al. Diagnosis of HIV-1 infection by PCR with two primer pairs. Eur J Epidemiol 1993;9:426-429.
30. St Louis D, Gotte D, Sanders-Buell E, et al. Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro. J Virol 1998;72:3991-3998.
31. Jauniaux E, Nessmann C, Imbert M, et al. Morphological aspects of the placenta in HIV pregnancies. Placenta 1988;9:633-642.
32. Gichangi P, Nyongo A, Temmerman M. Pregnancy outcome and placental weights: their relationship to HIV-1 infection. East Afr Med J 1993;70:85-89.
33. Mwanyumba F, Gaillard P, Inion I, et al. Placental inflammation and perinatal transmission of HIV-1. J Acquir Immune Defic Syndr 2002;29:262-269.
34. Chandwani S, Greco M, Mittal K, et al. Pathology and human immunodeficiency virus expression in placentas of seropositive women. J Infect Dis 1991;163:1134-1138.
35. Backe E, Jimenez E, Unger M, et al. Vertical human immunodeficiency virus transmission: a study of placental pathology in relation to maternal risk factors. Am J Perinatol 1994;11:326-330.
36. Temmerman M, Chomba E, Ndinya-Achola J, et al. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol 1994;83:495-501.
37. Benirschke K, Kaufmann P. Pathology of the Human Placenta. 4th edn. Springer-Verlag: New York, 2000.
38. Kumar R, Uduman S, Khurranna A. A prospective study of mother-to-infant HIV transmission in tribal women from India. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:238-242.
39. Van Dyke R, Korber B, Popek E, et al. The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy. J Infect Dis 1999;179:319-328.
40. Stringer J, Goldenberg R. Subclinical chorioamnionitis as a targetable risk factor for vertical transmission of HIV-1. Ann NY Acad Sci 2000;918:77-83.
41. Young N, Shaffer N, Chaowanachan T, et al. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J Acquir Immune Defic Syndr 2000;24:401-407.
42. Martin A, Brady K, Smith S, et al. Immunohistochemical localization of human immunodeficiency virus p24 antigen in placental tissue. Hum Pathol 1992;23:411-414.
43. Mattern C, Murray K, Jensen A, et al. Localization of human immunodeficiency virus core antigen in term human placentas. Pediatrics 1992;89:207-209.
44. Bhoopat L, Eiangleng L, Rugpao S, et al. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients. Mod Pathol 2001;14:1263-1269.
45. Goldenberg R, Vermund S, Goepfert A, et al. Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-1 transmission? Lancet 1998;352:1927-1930.
46. Lamont R, Duncan S, Mandal D, et al. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003;101:516-522.
47. Ugwumadu A, Manyonda I, Reid F, et al. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003;361:983-988.